Unilever PLC
NYSE:ULHousehold & Personal Products
+$0.57 today
- Market cap
- $139.02B
- Beta
- 0.45
- P/E (TTM)
- 25.5
- EPS (TTM)
- $1.99
- Dividend yield
- 3.84%
Volume 3.02M
Average 4.73M
UL Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
Unilever PLCNYSE: UL
Depreciation & Amortization · Q4 FY2025 · quarter ended Dec 2025
Depreciation & amortization declines year over year
Q4 FY2025 depreciation & amortization of €503.25M fell 47.7% year over year. Over 3 fiscal years it compounded at -3.6% a year.
Context
- Depreciation & amortization amounted to 2.7% of revenue in FY2025, down 0.2 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
EUR · from the cash flow
- Latest · FY2025
- 1.35B EUR
- Year-over-year change
- -23.0%
- 4-year CAGR
- -6.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.35B | -23.0% |
| FY2024 | 2024-12-31 | 1.76B | +11.3% |
| FY2023 | 2023-12-31 | 1.58B | +4.6% |
| FY2022 | 2022-12-31 | 1.51B | -13.6% |
| FY2021 | 2021-12-31 | 1.75B | — |
Depreciation & Amortization vs competitors
How UL compares with its peers on the latest reported figures
- Peers report in different currencies, so depreciation & amortization is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -23.0% is the lowest of 8, against a peer median of +2.8%.
- Depreciation & amortization amounts to 2.7% of revenue for UL, versus a peer median of 3.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $3.21B USD | +11.4% | +5.2% | 3.6% | |
| FY2025 | €1.35B EUR | -23.0% | -3.6% | 2.7% | |
| LTM Sep 2026 | $787M USD | -4.1% | +2.3% | 5.1% | |
| LTM Jun 2026 | $725M USD | -14.5% | +2.2% | 4.4% | |
| LTM Sep 2026 | $643M USD | +6.3% | +4.9% | 3.0% | |
| LTM Sep 2026 | $569M USD | +0.0% | -4.7% | 3.7% | |
| LTM Sep 2026 | $265M USD | +19.9% | +1.5% | 3.7% | |
| LTM Sep 2026 | $250.1M USD | +2.8% | +4.1% | 4.0% | |
| Peer median (excluding UL) | — | +2.8% | +2.3% | 3.7% | |
Competitors are the stored peer set for UL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 6.05B | 7.64B | 6.49B | 5.74B | 9.47B |
| Depreciation & Amortization | 1.75B | 1.51B | 1.58B | 1.76B | 1.35B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 161M | 177M | 212M | 324M | 255M |
| Change in Working Capital | (47M) | (422M) | 814M | (404M) | 111.42M |
| Accounts Receivables | (307M) | (1.85B) | 768M | (206M) | (2.52B) |
| Inventory | (458M) | (1.4B) | 340M | (198M) | (269.91M) |
| Accounts Payables | 733.88M | 2.73B | 0 | 0 | 2.9B |
| Other Working Capital | 0 | 0 | (294M) | 0 | 0 |
| Other Non-Cash Items | 63M | (1.62B) | 335M | 2.1B | (2.84B) |
| Operating Cash Flow | 7.97B | 7.28B | 9.43B | 9.52B | 8.35B |
| Capital Expenditures | (1.11B) | (1.46B) | (1.5B) | (1.74B) | (1.42B) |
| Acquisitions (Net) | (2.09B) | 3.64B | (268M) | 190M | (1.38B) |
| Purchases of Investments | (389M) | (290.21M) | (891M) | 0 | (188.26M) |
| Sales of Investments | 140.03M | 266M | 62M | 0 | 229.57M |
| Other Investing Activities | 198.97M | 290.21M | 305M | 923M | (246.97M) |
| Investing Cash Flow | (3.25B) | 2.45B | (2.29B) | (625M) | (3.12B) |
| Debt Repayment | 656M | (1.21B) | 497M | 643M | (1.44B) |
| Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased | (3.02B) | (1.51B) | (1.51B) | (1.51B) | (1.45B) |
| Dividends Paid | (4.48B) | (4.33B) | (4.36B) | (4.32B) | (4.28B) |
| Other Financing Activities | (254M) | (1.84B) | (1.82B) | (1.76B) | 351.57M |
| Financing Cash Flow | (7.1B) | (8.89B) | (7.19B) | (6.94B) | (6.81B) |
| Effect of Forex Changes | 285M | (7M) | (119M) | (48M) | (498M) |
| Net Change in Cash | (2.09B) | 838M | (180M) | 1.91B | (2.08B) |
| Free Cash Flow | 6.86B | 5.83B | 7.92B | 7.78B | 6.93B |
Unilever PLC
NYSE:UL
Intrinsic Alpha fair value
Locked
Current Price
$64.53
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.